01.09.22 | India’s Cumulative COVID-19 Vaccination Coverage exceeds 212.52 Cr

ad
health-ministry_indian-bureaucracy
health-ministry_indian-bureaucracy

India’s COVID-19 vaccination coverage has exceeded 212.52 Cr (2,12,52,83,259) as per provisional reports till 7 am today. COVID-19 vaccination for the age group 12-14 years was started on 16 March, 2022. So far, more than 4.03 Cr (4,03,43,557) adolescents have been administered with the first dose of COVID-19 vaccine. Similarly, the COVID-19 precaution dose administration for age group 18-59 years also started from 10th April, 2022 onwards. The break-up of the cumulative figure as per the provisional report till 7 am today include:

Cumulative Vaccine Dose Coverage
HCWs 1st Dose 1,04,14,101
2nd Dose 1,01,06,627
Precaution Dose 67,60,236
FLWs 1st Dose 1,84,34,615
2nd Dose 1,76,98,873
Precaution Dose 1,31,57,838
Age Group 12-14 years 1st Dose 4,03,43,557
2nd Dose 3,02,37,960
Age Group 15-18 years 1st Dose 6,16,86,394
2nd Dose 5,23,49,213
Age Group 18-44 years 1st Dose 56,06,05,033
2nd Dose 51,31,51,897
Precaution Dose 6,33,60,965
Age Group 45-59 years 1st Dose 20,39,07,321
2nd Dose 19,63,30,566
Precaution Dose 3,54,25,734
Over 60 years 1st Dose 12,75,82,332
2nd Dose 12,27,17,894
Precaution Dose 4,10,12,103
Precaution Dose 15,97,16,876
Total 2,12,52,83,259

India’s Active Caseload currently stands at 62,748. Active cases now constitute 0.14% of the country’s total Positive Cases.

image002OL9SConsequently, India’s recovery rate stands at 98.67%. 9,828 patients have recovered in the last 24 hours and the cumulative tally of recovered patients (since the beginning of the pandemic) is now at 4,38,45,680.

image003909B

7,946 new cases were reported in the last 24 hours.

image004K5WS

The last 24 hours saw a total of 2,66,477 COVID-19 tests being conducted. India has so far conducted over 88.61 Cr (88,61,47,613) cumulative tests. Weekly Positivity Rate in the country currently stands at 2.57% and the Daily Positivity rate is reported to be 2.98%.

image005MSV0

Be the first to comment

Leave a Reply